Patents Assigned to STRIKE PHARMA AB
  • CD40 binding protein, bispecific conjugate thereof and method of treating cancer
    Patent number: 12630643
    Abstract: Provided is a binding protein that binds CD40 and is an agonist thereof. In a particular embodiment the invention provides an agonistic anti-CD40 antibody. Also provided are bispecific conjugates comprising the binding protein, and complexes comprising the bispecific conjugates non-covalently bound to a tag construct comprising an antigen, for antigen delivery to immune cells. Medical uses of the binding proteins, conjugates and complexes of the invention are also provided.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: May 19, 2026
    Assignee: STRIKE PHARMA AB
    Inventors: Sara Mangsbo, Helena Persson Lotsholm, Oskar Andersson